{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:57:48Z","timestamp":1781647068121,"version":"3.54.5"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>The association between the Triglyceride-Glucose index, an emerging marker of insulin resistance, and the risk of aortic stenosis remains unclear. The influence of Triglyceride-Glucose index on aortic stenosis may be mediated through plasma metabolites. To investigate the potential causal relationships between the Triglyceride-Glucose index, plasma metabolites, and aortic stenosis, we employed a two-sample Mendelian randomization approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted univariable Mendelian randomization analyses to explore the associations between (i) the Triglyceride-Glucose index and aortic stenosis; (ii) plasma metabolites and aortic stenosis; and (iii) the Triglyceride-Glucose index and plasma metabolites. For significant associations identified through Mendelian randomization, a two-step MR analysis was employed to evaluate mediation effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The genetically predicted Triglyceride-Glucose index is positively associated with aortic stenosis (OR 1.74, 95% confidence interval 1.41, 2.16). Following adjustments for multiple testing, there were 15 notable associations between genetically predicted metabolites and aortic stenosis. Additional analyses estimated the indirect effects of the TyG index on AS through these metabolites. Notably, the mediation effect of various metabolites was quantified: 1-arachidonoyl-gpc (20:4n6) exhibited a mediation effect of 0.06 (95% CI: 0.02 to 0.11,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20094.38E-03); 1-stearoyl-2-arachidonoyl-gpc (18:0\/20:4) had a mediation effect of 0.08 (95% CI: 0.03 to 0.12,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20096.60E-04); 1-stearoyl-2-arachidonoyl-gpe (18:0\/20:4) showed an effect of 0.12 (95% CI: 0.06 to 0.17,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20096.58E-05); 1-palmitoyl-2-arachidonoyl-gpe (16:0\/20:4) demonstrated a mediation effect of 0.07 (95% CI: 0.03 to 0.11,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20098.75E-04); 1-palmitoyl-2-docosahexaenoyl-gpe (16:0\/22:6) showed an effect of 0.09 (95% CI: 0.03 to 0.14,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20091.26E-03); and 1-oleoyl-2-arachidonoyl-gpe (18:1\/20:4) had an effect of 0.08 (95% CI: 0.03 to 0.13,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20095.38E-04).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The genetically predicted Triglyceride-Glucose index is positively associated with the risk of aortic stenosis, and this relationship is partially mediated by specific metabolites.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13019-026-03976-3","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T17:35:28Z","timestamp":1775496928000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Triglyceride-glucose index, plasma metabolome and aortic stenosis: a Mendelian randomization analysis"],"prefix":"10.1186","volume":"21","author":[{"given":"Zhisheng","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"3976_CR1","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1136\/heartjnl-2016-310894","volume":"103","author":"P Andell","year":"2017","unstructured":"Andell P, et al. Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study. Heart (British Cardiac Society) vol. 2017;103:1696\u2013703. https:\/\/doi.org\/10.1136\/heartjnl-2016-310894.","journal-title":"Heart (British Cardiac Society) vol"},{"key":"3976_CR2","doi-asserted-by":"publisher","unstructured":"Danielsen R et al. The prevalence of aortic stenosis in the elderly in Iceland and predictions for the coming decades: the AGES-Reykjav\u00edk study. Int J Cardiol 176,3 (2014): 916\u201322. https:\/\/doi.org\/10.1016\/j.ijcard.2014.08.053","DOI":"10.1016\/j.ijcard.2014.08.053"},{"issue":"5","key":"3976_CR3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1161\/CIRCOUTCOMES.112.966002","volume":"5","author":"MA Clark","year":"2012","unstructured":"Clark MA, et al. Five-year clinical and economic outcomes among patients with medically managed severe aortic stenosis: results from a Medicare claims analysis. Circulation Cardiovasc Qual outcomes vol. 2012;5(5):697\u2013704. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.112.966002.","journal-title":"Circulation Cardiovasc Qual outcomes vol"},{"issue":"3","key":"3976_CR4","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/s0735-1097(96)00563-3","volume":"29","author":"BF Stewart","year":"1997","unstructured":"Stewart BF, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol vol. 1997;29(3):630\u20134. https:\/\/doi.org\/10.1016\/s0735-1097(96)00563-3.","journal-title":"J Am Coll Cardiol vol"},{"issue":"7","key":"3976_CR5","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, Simental-Mend\u00eda LE, Gonz\u00e1lez-Ortiz M, Mart\u00ednez-Abundis E, Ramos-Zavala MG, Hern\u00e1ndez-Gonz\u00e1lez SO, Jacques-Camarena O, Rodr\u00edguez-Mor\u00e1n M. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347\u201351. https:\/\/doi.org\/10.1210\/jc.2010-0288.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"3976_CR6","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/pedi.12303","volume":"17","author":"NS Mohd Nor","year":"2016","unstructured":"Mohd Nor NS, Lee S, Bacha F, Tfayli H, Arslanian S. Triglyceride glucose index as a surrogate measure of insulin sensitivity in obese adolescents with normoglycemia, prediabetes, and type 2 diabetes mellitus: comparison with the hyperinsulinemic-euglycemic clamp. Pediatr Diabetes. 2016;17(6):458\u201365. https:\/\/doi.org\/10.1111\/pedi.12303.","journal-title":"Pediatr Diabetes"},{"issue":"8","key":"3976_CR7","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41569-023-00845-7","volume":"20","author":"LM Moncla","year":"2023","unstructured":"Moncla LM, Briend M, Boss\u00e9 Y, Mathieu P. Calcific aortic valve disease: mechanisms, prevention and treatment. Nat Rev Cardiol. 2023;20(8):546\u201359. https:\/\/doi.org\/10.1038\/s41569-023-00845-7.","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"3976_CR8","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s40520-020-01681-2","volume":"33","author":"M Conte","year":"2021","unstructured":"Conte M, Petraglia L, Campana P, et al. The role of inflammation and metabolic risk factors in the pathogenesis of calcific aortic valve stenosis. Aging Clin Exp Res. 2021;33(7):1765\u201370. https:\/\/doi.org\/10.1007\/s40520-020-01681-2.","journal-title":"Aging Clin Exp Res"},{"issue":"2","key":"3976_CR9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.15420\/ecr.2015.10.2.108","volume":"10","author":"DA Lerman","year":"2015","unstructured":"Lerman DA, Prasad S, Alotti N. Calcific Aortic Valve Disease: Molecular Mechanisms and Therapeutic Approaches. Eur Cardiol. 2015;10(2):108\u201312. https:\/\/doi.org\/10.15420\/ecr.2015.10.2.108.","journal-title":"Eur Cardiol"},{"issue":"1","key":"3976_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12933-021-01268-9","volume":"20","author":"X Ding","year":"2021","unstructured":"Ding X, Wang X, Wu J, Zhang M, Cui M. Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol. 2021;20(1):76. https:\/\/doi.org\/10.1186\/s12933-021-01268-9.","journal-title":"Cardiovasc Diabetol"},{"key":"3976_CR11","doi-asserted-by":"publisher","first-page":"784616","DOI":"10.3389\/fendo.2021.784616","volume":"12","author":"S Zou","year":"2021","unstructured":"Zou S, Yang C, Shen R, Wei X, Gong J, Pan Y, Lv Y, Xu Y. Association Between the Triglyceride-Glucose Index and the Incidence of Diabetes in People With Different Phenotypes of Obesity: A Retrospective Study. Front Endocrinol (Lausanne). 2021;12:784616. https:\/\/doi.org\/10.3389\/fendo.2021.784616.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3976_CR12","doi-asserted-by":"publisher","unstructured":"Li X et al. Nov. Triglyceride-glucose index and the risk of heart failure: Evidence from two large cohorts and a mendelian randomization analysis. Cardiovascular diabetology vol. 21,1 229. 3 2022, https:\/\/doi.org\/10.1186\/s12933-022-01658-7","DOI":"10.1186\/s12933-022-01658-7"},{"issue":"3","key":"3976_CR13","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jaci.2022.04.006","volume":"150","author":"J-X Li","year":"2022","unstructured":"Li J-X, et al. Untargeted metabolomic profiling identifies disease-specific and outcome-related signatures in chronic rhinosinusitis. J allergy Clin Immunol vol. 2022;150(3):727\u2013e7356. https:\/\/doi.org\/10.1016\/j.jaci.2022.04.006.","journal-title":"J allergy Clin Immunol vol"},{"issue":"7","key":"3976_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.5694\/mja2.51464","volume":"216","author":"VM McDonald","year":"2022","unstructured":"McDonald VM, Peter G, Gibson. Treatable traits in asthma: moving beyond diagnostic labels. Med J Australia vol. 2022;216(7):331\u20133. https:\/\/doi.org\/10.5694\/mja2.51464.","journal-title":"Med J Australia vol"},{"issue":"7","key":"3976_CR15","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1038\/s41401-021-00804-3","volume":"43","author":"YY He","year":"2022","unstructured":"He YY, Yan Y, Chen JW, et al. Plasma metabolomics in the perioperative period of defect repair in patients with pulmonary arterial hypertension associated with congenital heart disease. Acta Pharmacol Sin 2022;43(7):1710\u201320. https:\/\/doi.org\/10.1038\/s41401-021-00804-3.","journal-title":"Acta Pharmacol Sin"},{"key":"3976_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41698-022-00299-z","volume":"6","author":"NA Fraunhoffer","year":"2022","unstructured":"Fraunhoffer NA, et al. Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction. NPJ Precis Oncol. 2022;6:57. https:\/\/doi.org\/10.1038\/s41698-022-00299-z.","journal-title":"NPJ Precis Oncol"},{"issue":"7","key":"3976_CR17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrd.2016.32","volume":"15","author":"DS Wishart","year":"2016","unstructured":"Wishart DS. Emerging applications of metabolomics in drug discovery and precision medicine. Nat reviews Drug discovery vol. 2016;15(7):473\u201384. https:\/\/doi.org\/10.1038\/nrd.2016.32.","journal-title":"Nat reviews Drug discovery vol"},{"issue":"1","key":"3976_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","volume":"32","author":"GD Smith","year":"2003","unstructured":"Smith GD, Ebrahim S. Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol vol. 2003;32(1):1\u201322. https:\/\/doi.org\/10.1093\/ije\/dyg070.","journal-title":"Int J Epidemiol vol"},{"key":"3976_CR19","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1136\/bmj.330.7499.1076","volume":"330","author":"G Davey Smith","year":"2005","unstructured":"Davey Smith G, Ebrahim S. What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? BMJ. 2005;330:1076\u20139. https:\/\/doi.org\/10.1136\/bmj.330.7499.1076.","journal-title":"BMJ"},{"key":"3976_CR20","doi-asserted-by":"publisher","unstructured":"Wehby GL et al. \u2018Mendelian randomization\u2019 equals instrumental variable analysis with genetic instruments. Stat Med 27,15 (2008): 2745\u20139. https:\/\/doi.org\/10.1002\/sim.3255","DOI":"10.1002\/sim.3255"},{"issue":"1","key":"3976_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/ije\/dyh048","volume":"33","author":"DC Thomas","year":"2004","unstructured":"Thomas DC. Commentary: the concept of \u2018Mendelian Randomization\u2019. Int J Epidemiol vol. 2004;33(1):21\u20135. https:\/\/doi.org\/10.1093\/ije\/dyh048.","journal-title":"Int J Epidemiol vol"},{"issue":"1","key":"3976_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00439-007-0448-6","volume":"123","author":"S Ebrahim","year":"2008","unstructured":"Ebrahim S. Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology? Hum Genet vol. 2008;123(1):15\u201333. https:\/\/doi.org\/10.1007\/s00439-007-0448-6.","journal-title":"Hum Genet vol"},{"key":"3976_CR23","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet vol. 2014;23:R89\u201398. https:\/\/doi.org\/10.1093\/hmg\/ddu328.","journal-title":"Hum Mol Genet vol"},{"key":"3976_CR24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.3","volume":"4","author":"S Burgess","year":"2023","unstructured":"Burgess S, Davey Smith G, Davies NM, et al. Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res. 2023;4:186. https:\/\/doi.org\/10.12688\/wellcomeopenres.15555.3. Published 2023 Aug 4.","journal-title":"Wellcome Open Res"},{"key":"3976_CR25","doi-asserted-by":"publisher","unstructured":"Si S et al. Jan. Causal Effect of the Triglyceride-Glucose Index and the Joint Exposure of Higher Glucose and Triglyceride With Extensive Cardio-Cerebrovascular Metabolic Outcomes in the UK Biobank: A Mendelian Randomization Study. Frontiers in cardiovascular medicine vol. 7 583473. 22 2021, https:\/\/doi.org\/10.3389\/fcvm.2020.583473","DOI":"10.3389\/fcvm.2020.583473"},{"key":"3976_CR26","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nat vol. 2023;613:508\u201318. https:\/\/doi.org\/10.1038\/s41586-022-05473-8.","journal-title":"Nat vol"},{"issue":"1","key":"3976_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41588-022-01270-1","volume":"55","author":"Y Chen","year":"2023","unstructured":"Chen Y, et al. Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases. Nat Genet vol. 2023;55(1):44\u201353. https:\/\/doi.org\/10.1038\/s41588-022-01270-1.","journal-title":"Nat Genet vol"},{"issue":"R2","key":"3976_CR28","doi-asserted-by":"publisher","first-page":"R195","DOI":"10.1093\/hmg\/ddy163","volume":"27","author":"G Hemani","year":"2018","unstructured":"Hemani G, Bowden J, Davey Smith G. Evaluating the potential role of pleiotropy in Mendelian randomization studies. Hum Mol Genet. 2018;27(R2):R195\u2013208. https:\/\/doi.org\/10.1093\/hmg\/ddy163.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"3976_CR29","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1093\/ije\/dyy101","volume":"47","author":"J Bowden","year":"2018","unstructured":"Bowden J, et al. Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the Radial plot and Radial regression. Int J Epidemiol. 2018;47(4):1264\u201378. https:\/\/doi.org\/10.1093\/ije\/dyy101.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"3976_CR30","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1198\/073500102288618658","volume":"20","author":"JH Stock","year":"2002","unstructured":"Stock JH, Wright JH, Yogo M. A Survey of Weak Instruments and Weak Identification in Generalized Method of Moments. J Bus Economic Stat. 2002;20(4):518\u201329. https:\/\/doi.org\/10.1198\/073500102288618658.","journal-title":"J Bus Economic Stat"},{"issue":"4","key":"3976_CR31","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1177\/1536867X0800700402","volume":"7","author":"CF Baum","year":"2007","unstructured":"Baum CF, Schaffer ME, Stillman S. Enhanced Routines for Instrumental Variables\/Generalized Method ofMoments Estimation and Testing. Stata J. 2007;7(4):465\u2013506. https:\/\/doi.org\/10.1177\/1536867X0800700402.","journal-title":"Stata J"},{"issue":"3","key":"3976_CR32","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG, CRP CHD Genetics Collaboration. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40(3):755\u201364. https:\/\/doi.org\/10.1093\/ije\/dyr036.","journal-title":"Int J Epidemiol"},{"key":"3976_CR33","doi-asserted-by":"publisher","unstructured":"Shim H et al. Apr. A multivariate genome-wide association analysis of 10 LDL subfractions, and their response to statin treatment, in 1868 Caucasians. PloS one vol. 10,4 e0120758. 21 2015, https:\/\/doi.org\/10.1371\/journal.pone.0120758","DOI":"10.1371\/journal.pone.0120758"},{"issue":"11","key":"3976_CR34","doi-asserted-by":"publisher","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","volume":"13","author":"G Hemani","year":"2017","unstructured":"Hemani G, Tilling K, Davey Smith G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data [published correction appears in PLoS Genet. 2017;13(12):e1007149]. PLoS Genet. 2017;13(11):e1007081. https:\/\/doi.org\/10.1371\/journal.pgen.1007081. Published 2017 Nov 17.","journal-title":"PLoS Genet"},{"issue":"5","key":"3976_CR35","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/ije\/dyt179","volume":"42","author":"MJ Brion","year":"2013","unstructured":"Brion MJ, Shakhbazov K, Visscher PM. Calculating statistical power in Mendelian randomization studies. Int J Epidemiol. 2013;42(5):1497\u2013501. https:\/\/doi.org\/10.1093\/ije\/dyt179.","journal-title":"Int J Epidemiol"},{"issue":"7","key":"3976_CR36","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658\u201365. https:\/\/doi.org\/10.1002\/gepi.21758.","journal-title":"Genet Epidemiol"},{"issue":"3","key":"3976_CR37","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1214\/19-AOS1866","volume":"48","author":"Q Zhao","year":"2020","unstructured":"Zhao Q, Wang J, Hemani G, et al. Statistical inference in two-sample summary-data Mendelian randomization using robust adjusted profile score. Ann Stat. 2020;48(3):1742\u201369. https:\/\/doi.org\/10.1214\/19-AOS1866.","journal-title":"Ann Stat"},{"issue":"4","key":"3976_CR38","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, et al. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genetic Epidemiol vol. 2016;40(4):304\u201314. https:\/\/doi.org\/10.1002\/gepi.21965.","journal-title":"Genetic Epidemiol vol"},{"issue":"1","key":"3976_CR39","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41467-019-14156-4","volume":"11","author":"S Burgess","year":"2020","unstructured":"Burgess S, Foley CN, Allara E, Staley JR, Howson JMM. A robust and efficient method for Mendelian randomization with hundreds of genetic variants. Nat Commun. 2020;11(1):376. https:\/\/doi.org\/10.1038\/s41467-019-14156-4. Published 2020 Jan 17.","journal-title":"Nat Commun"},{"issue":"2","key":"3976_CR40","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512\u201325. https:\/\/doi.org\/10.1093\/ije\/dyv080.","journal-title":"Int J Epidemiol"},{"key":"3976_CR41","doi-asserted-by":"publisher","unstructured":"Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases [published correction appears in Nat Genet. 2018;50(8):1196]. Nat Genet. 2018;50(5):693\u2013698. https:\/\/doi.org\/10.1038\/s41588-018-0099-7","DOI":"10.1038\/s41588-018-0099-7"},{"issue":"21","key":"3976_CR42","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1002\/sim.6522","volume":"34","author":"MFD Greco","year":"2015","unstructured":"Greco MFD, Minelli C, Sheehan NA, Thompson JR. Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome. Stat Med. 2015;34(21):2926\u201340. https:\/\/doi.org\/10.1002\/sim.6522.","journal-title":"Stat Med"},{"issue":"12","key":"3976_CR43","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1093\/aje\/kwy185Q","volume":"187","author":"J Bowden","year":"2018","unstructured":"Bowden J, Hemani G, Davey Smith G. Invited Commentary: Detecting Individual and Global Horizontal Pleiotropy in Mendelian Randomization-A Job for the Humble Heterogeneity Statistic? Am J Epidemiol. 2018;187(12):2681\u20135. https:\/\/doi.org\/10.1093\/aje\/kwy185Q.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"3976_CR44","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/EDE.0000000000000559","volume":"28","author":"S Burgess","year":"2017","unstructured":"Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG. Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants. Epidemiology. 2017;28(1):30\u201342. https:\/\/doi.org\/10.1097\/EDE.0000000000000559.","journal-title":"Epidemiology"},{"issue":"10","key":"3976_CR45","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.2337\/db16-0418","volume":"65","author":"LJ Corbin","year":"2016","unstructured":"Corbin LJ, Richmond RC, Wade KH, et al. BMI as a Modifiable Risk Factor for Type 2 Diabetes: Refining and Understanding Causal Estimates Using Mendelian Randomization. Diabetes. 2016;65(10):3002\u20137. https:\/\/doi.org\/10.2337\/db16-0418.","journal-title":"Diabetes"},{"key":"3976_CR46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-publhealth-032315-021402","volume":"37","author":"TJ VanderWeele","year":"2016","unstructured":"VanderWeele TJ. Mediation Analysis: A Practitioner\u2019s Guide. Annu Rev Public Health. 2016;37:17\u201332. https:\/\/doi.org\/10.1146\/annurev-publhealth-032315-021402.","journal-title":"Annu Rev Public Health"},{"key":"3976_CR47","doi-asserted-by":"publisher","unstructured":"Carter AR et al. May. Understanding the consequences of education inequality on cardiovascular disease: mendelian randomisation study. BMJ (Clinical research ed.) vol. 365 l1855. 22 2019, https:\/\/doi.org\/10.1136\/bmj.l1855","DOI":"10.1136\/bmj.l1855"},{"key":"3976_CR48","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/postmj\/qgae085","volume":"100","author":"P Wang","year":"2024","unstructured":"Wang P, et al. Association of TyG index with aortic valve calcification in valvular heart disease patients. Postgrad Med J vol. 2024;100:917\u201324. https:\/\/doi.org\/10.1093\/postmj\/qgae085.","journal-title":"Postgrad Med J vol"},{"issue":"1","key":"3976_CR49","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4093\/dmj.2021.0280","volume":"46","author":"S-H Lee","year":"2022","unstructured":"Lee S-H, et al. Insulin Resistance: From Mechanisms to Therapeutic Strategies. Diabetes metabolism J vol. 2022;46(1):15\u201337. https:\/\/doi.org\/10.4093\/dmj.2021.0280.","journal-title":"Diabetes metabolism J vol"},{"key":"3976_CR50","doi-asserted-by":"publisher","unstructured":"Boucher J\u00e9r\u00e9mie et al. Jan. Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harbor perspectives in biology vol. 6,1 a009191. 1 2014, https:\/\/doi.org\/10.1101\/cshperspect.a009191","DOI":"10.1101\/cshperspect.a009191"},{"issue":"9","key":"3976_CR51","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1016\/j.bbadis.2019.05.019","volume":"1865","author":"JI Selig","year":"2019","unstructured":"Selig JI, et al. Impact of hyperinsulinemia and hyperglycemia on valvular interstitial cells - A link between aortic heart valve degeneration and type 2 diabetes. Biochimica et biophysica acta. Mol basis disease vol. 2019;1865(9):2526\u201337. https:\/\/doi.org\/10.1016\/j.bbadis.2019.05.019.","journal-title":"Mol basis disease vol"},{"issue":"12","key":"3976_CR52","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.jacbts.2020.10.001","volume":"5","author":"A Surendran","year":"2020","unstructured":"Surendran A, Edel A, Chandran M, Bogaert P, Hassan-Tash P, Kumar Asokan A, Hiebert B, Solati Z, Sandhawalia S, Raabe M, Kass M, Shah A, Jassal DS, Jaleel A, Ravandi A. Metabolomic Signature of Human Aortic Valve Stenosis. JACC Basic Transl Sci. 2020;5(12):1163\u201377. PMID: 33426374; PMCID: PMC7775961.","journal-title":"JACC Basic Transl Sci"},{"key":"3976_CR53","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ijcard.2016.09.089","volume":"225","author":"L Mourino-Alvarez","year":"2016","unstructured":"Mourino-Alvarez L, Baldan-Martin M, Gonzalez-Calero L, Martinez-Laborde C, Sastre-Oliva T, Moreno-Luna R, et al. Patients with calcific aortic stenosis exhibit systemic molecular evidence of ischemia, enhanced coagulation, oxidative stress and impaired cholesterol transport. Int J Cardiol. 2016;225:99\u2013106. https:\/\/doi.org\/10.1016\/j.ijcard.2016.09.089.","journal-title":"Int J Cardiol"},{"issue":"7","key":"3976_CR54","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.3390\/ijms22073569","volume":"22","author":"BO van Driel","year":"2021","unstructured":"van Driel BO, Schuldt M, Alg\u00fcl S, Levin E, G\u00fccl\u00fc A, Germans T, Rossum ACV, Pei J, Harakalova M, Baas A, Jans JJM, van der Velden J. Metabolomics in Severe Aortic Stenosis Reveals Intermediates of Nitric Oxide Synthesis as Most Distinctive Markers. Int J Mol Sci. 2021;22(7):3569. https:\/\/doi.org\/10.3390\/ijms22073569. PMID: 33808189; PMCID: PMC8037707.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"3976_CR55","doi-asserted-by":"publisher","first-page":"e0242019","DOI":"10.1371\/journal.pone.0242019","volume":"15","author":"C Al Hageh","year":"2020","unstructured":"Al Hageh C, Rahy R, Khazen G, Brial F, Khnayzer RS, Gauguier D, Zalloua PA. Plasma and urine metabolomic analyses in aortic valve stenosis reveal shared and biofluid-specific changes in metabolite levels. PLoS ONE. 2020;15(11):e0242019. https:\/\/doi.org\/10.1371\/journal.pone.0242019. PMID: 33237940; PMCID: PMC7688110.","journal-title":"PLoS ONE"},{"issue":"8","key":"3976_CR56","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3390\/metabo14080457","volume":"14","author":"H Al-Sulaiti","year":"2024","unstructured":"Al-Sulaiti H, Anwardeen N, Bashraheel SS, Naja K, Elrayess MA. Alterations in Choline Metabolism in Non-Obese Individuals with Insulin Resistance and Type 2 Diabetes Mellitus. Metabolites. 2024;14(8):457. https:\/\/doi.org\/10.3390\/metabo14080457. PMID: 39195553; PMCID: PMC11356528.","journal-title":"Metabolites"},{"key":"3976_CR57","doi-asserted-by":"publisher","unstructured":"Fu B, Wang J, Wang L et al. Integrated proteomic and metabolomic profile analyses of cardiac valves revealed molecular mechanisms and targets in calcific aortic valve disease. Front Cardiovasc Med. 2022;9:944521. Published 2022 Oct 13. https:\/\/doi.org\/10.3389\/fcvm.2022.944521","DOI":"10.3389\/fcvm.2022.944521"},{"issue":"25","key":"3976_CR58","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/j.jacc.2024.08.070","volume":"84","author":"HS Bhatia","year":"2024","unstructured":"Bhatia HS, Dweck MR, Craig N, et al. Oxidized Phospholipids and Calcific Aortic Valvular Disease. J Am Coll Cardiol. 2024;84(25):2430\u201341. https:\/\/doi.org\/10.1016\/j.jacc.2024.08.070.","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"3976_CR59","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1007\/s00018-015-1982-3","volume":"72","author":"TO Eichmann","year":"2015","unstructured":"Eichmann TO, Lass A. DAG tales: the multiple faces of diacylglycerol\u2013stereochemistry, metabolism, and signaling. Cell Mol Life Sci. 2015;72(20):3931\u201352. https:\/\/doi.org\/10.1007\/s00018-015-1982-3.","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"3976_CR60","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.34067\/KID.0000000797","volume":"6","author":"SM Laville","year":"2025","unstructured":"Laville SM, Jaisson S, Gillery P, et al. Homocitrulline Is Associated with Cardiovascular Outcomes in Nondialysis Patients with CKD. Kidney360. 2025;6(8):1328\u201337. https:\/\/doi.org\/10.34067\/KID.0000000797. Published 2025 Apr 1.","journal-title":"Kidney360"},{"issue":"1","key":"3976_CR61","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1515\/cclm-2014-0642","volume":"53","author":"S Jaisson","year":"2015","unstructured":"Jaisson S, Kerkeni M, Santos-Weiss IC, Addad F, Hammami M, Gillery P. Increased serum homocitrulline concentrations are associated with the severity of coronary artery disease. Clin Chem Lab Med. 2015;53(1):103\u201310. https:\/\/doi.org\/10.1515\/cclm-2014-0642.","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"3976_CR62","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.kint.2021.10.018","volume":"101","author":"V Jankowski","year":"2022","unstructured":"Jankowski V, Saritas T, Kjolby M, et al. Carbamylated sortilin associates with cardiovascular calcification in patients with chronic kidney disease. Kidney Int. 2022;101(3):574\u201384. https:\/\/doi.org\/10.1016\/j.kint.2021.10.018.","journal-title":"Kidney Int"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-026-03976-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-03976-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-03976-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:33:16Z","timestamp":1781645596000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13019-026-03976-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3976"],"URL":"https:\/\/doi.org\/10.1186\/s13019-026-03976-3","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"246"}}